APA (7th ed.) Citation

RV, O., H, A., C, H., N, R., & EM, B. (2026). The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71030

Chicago Style (17th ed.) Citation

RV, Overgaard, Agersø H, Hollensen C, Rathor N, and Bomberg EM. "The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies." Diabetes, Obesity & Metabolism 2026. https://doi.org/10.1111/dom.71030.

MLA (9th ed.) Citation

RV, Overgaard, et al. "The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies." Diabetes, Obesity & Metabolism, 2026, https://doi.org/10.1111/dom.71030.